<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016518"><a href="http://purl.obolibrary.org/obo/MONDO_0016518">MONDO:0016518</a></h3>
<p><strong>Label:</strong> isolated punctate palmoplantar keratoderma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019332">MONDO:0019332</a> (punctate palmoplantar keratoderma type 1), <a href="http://purl.obolibrary.org/obo/MONDO_0017676">MONDO:0017676</a> (marginal papular palmoplantar keratoderma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_79501">Orphanet:79501</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614936">OMIM:614936</a>, <a href="http://www.orpha.net/ORDO/Orphanet_307995">Orphanet:307995</a>, <a href="http://purl.obolibrary.org/obo/OMIM_148600">OMIM:148600</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) and <a href="http://purl.obolibrary.org/obo/HP_0100834">HP:0100834</a> (Neoplasm of the large intestine) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) and <a href="http://purl.obolibrary.org/obo/HP_0100273">HP:0100273</a> (Neoplasm of the colon) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) and <a href="http://purl.obolibrary.org/obo/HP_0100013">HP:0100013</a> (Neoplasm of the breast) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) and <a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010786">HP:0010786</a> (Urinary tract neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009726">HP:0009726</a> (Renal neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009725">HP:0009725</a> (Bladder neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007379">HP:0007379</a> (Neoplasm of the genitourinary tract) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007378">HP:0007378</a> (Neoplasm of the gastrointestinal tract) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and <a href="http://purl.obolibrary.org/obo/HP_0100273">HP:0100273</a> (Neoplasm of the colon) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and <a href="http://purl.obolibrary.org/obo/HP_0011138">HP:0011138</a> (Abnormality of skin adnexa morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005584">HP:0005584</a> (Renal cell carcinoma) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) 62.50%</li>
</ul>
</body>
</html>
